Driving Scientific Breakthroughs with Advanced Assay Development
On-Demand Recording
Thanks for your interest in our webinar exploring the cutting-edge capabilities of Quanterix's Accelerator Laboratory. As a leader in ultra-sensitive immunoassays, Quanterix offers a wide range of biomarker tests across neurology, inflammation, oncology, and infectious diseases. Learn how our services can streamline your research and clinical trials, driving your scientific breakthroughs.
In this webinar, Dr. Matthew C. Havrda, Associate Professor at Dartmouth’s Geisel School of Medicine, shared his research on neuroinflammation in Parkinson’s disease. His work, in collaboration with Quanterix and the Michael J. Fox Foundation, has led to the development of highly sensitive assays for inflammasome-related proteins. His insights show how these advanced assays can detect inflammasome activity in patient biofluids, aiding in patient stratification and treatment. Access the on-demand webinar to learn more.